Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Fortis Healthcare Ltd.
Source DateBoard Meeting DateDetails
30-Oct-2024 08-Nov-2024 Quarterly Results
04-Oct-2024 09-Oct-2024 Inter alia, to consider and approve the issue of Non-Convertible Debentures (NCD)
28-Aug-2024 30-Aug-2024 Fund Raising
30-Jul-2024 06-Aug-2024 Quarterly Results
16-May-2024 23-May-2024 Audited Results & Final Dividend
31-Jan-2024 07-Feb-2024 Quarterly Results
03-Nov-2023 10-Nov-2023 Quarterly Results
31-Jul-2023 04-Aug-2023 Quarterly Results
16-May-2023 23-May-2023 Audited Results & Final Dividend
03-Feb-2023 10-Feb-2023 Quarterly Results
03-Nov-2022 11-Nov-2022 Quarterly Results
28-Jul-2022 05-Aug-2022 Quarterly Results
18-May-2022 25-May-2022 Audited Results
04-Feb-2022 11-Feb-2022 Quarterly Results
08-Nov-2021 12-Nov-2021 Quarterly Results
06-Aug-2021 13-Aug-2021 Quarterly Results
24-May-2021 29-May-2021 Audited Results
29-Jan-2021 05-Feb-2021 Quarterly Results
05-Nov-2020 12-Nov-2020 Quarterly Results
07-Aug-2020 14-Aug-2020 Quarterly Results
Page 1 of 5
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.